Home › Funds › TANG CAPITAL MANAGEMENT LLC › VRDN

TANG CAPITAL MANAGEMENT LLC position in VRDN

VIRIDIAN THERAPEUTICS INC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 1,792,626 shares of VRDN (VIRIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$36.9M, representing 1.70% of its reported portfolio and ranking #17 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed VRDN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.79M sh
Reported value held$36.91M
Portfolio Weight1.70%
First reportedQ3 2023
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's VRDN position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in VRDN in Q3 2023 at 669,125 shares (US$10.3M). The position peaked in Q3 2025 at 2,842,925 shares, worth US$61.4M. Across 13 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 1,792,626 shares valued at US$36.9M. Notable position changes include a 101% increase in Q2 2024 (shares rose 75% over the following quarter), a 61% increase in Q3 2024 (shares fell 16% over the following quarter), a 37% trim in Q4 2025 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 669.12K $10.26M New
Q4 2023 692.92K $15.09M Add
Q1 2024 692.92K $12.13M Hold
Q2 2024 1.39M $18.12M Add
Q3 2024 2.24M $51.03M Add
Q4 2024 2.49M $47.79M Add
Q1 2025 2.79M $37.65M Add
Q2 2025 2.84M $39.74M Add
Q3 2025 2.84M $61.35M Hold
Q4 2025 1.79M $55.79M Reduce
Q1 2026 1.79M $35.06M Hold
Q2 2026 1.79M $32.93M Hold
Q3 2026 1.79M $36.91M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRDN and 13F data

VRDN (VIRIDIAN THERAPEUTICS INC) is a Health Care company. 40 other funds we track also report a position in VRDN — the largest reported positions include Paradigm Biocapital Advisors LP (US$227.1M), Bellevue Group AG (US$146.4M), Kynam Capital Management, LP (US$126.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held VRDN?

TANG CAPITAL MANAGEMENT LLC has disclosed VRDN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in VRDN?

As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 1.79M shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $36.91M, representing 1.70% of its reported portfolio and ranking #17.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling VRDN?

In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in VRDN. The position peaked in Q3 2025 at 2.84M shares.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Paradigm Biocapital Advisors LP, Bellevue Group AG, Kynam Capital Management, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.